Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay
Objective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to i...
Main Authors: | , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Hindawi Limited
2021-01-01
|
Series: | Multiple Sclerosis International |
Online Access: | http://dx.doi.org/10.1155/2021/8692328 |
id |
doaj-d0d7b899e2834237870a4145c0789a6a |
---|---|
record_format |
Article |
spelling |
doaj-d0d7b899e2834237870a4145c0789a6a2021-10-11T00:39:12ZengHindawi LimitedMultiple Sclerosis International2090-26622021-01-01202110.1155/2021/8692328Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used AssayJon P. Williams0Justin R. Abbatemarco1Jonathan J. Galli2Stefanie J. Rodenbeck3Lisa K. Peterson4Thomas R. Haven5Meagan Street6John W. Rose7John E. Greenlee8M. Mateo Paz Soldan9Stacey L. Clardy10Department of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyARUP Institute for Clinical and Experimental PathologyARUP Institute for Clinical and Experimental PathologyARUP Institute for Clinical and Experimental PathologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyDepartment of NeurologyObjective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to identify all patients at the University of Utah who had AQP4 ELISA testing at ARUP Laboratories from 2010 to 2017. We then reviewed their diagnostic evaluation and final diagnosis based on the ELISA titer result. Results. A total of 750 tests for the AQP4 ELISA were analyzed, and 47 unique patients with positive titers were identified. Less than half of these patients (49%) met the clinical criteria for neuromyelitis optica spectrum disorder (NMOSD). In cases of low positive titers (3.0–7.9 U/mL, n=19), the most common final diagnosis was multiple sclerosis (52.6%). In the moderate positive cohort (8.0–79.9 U/mL, n=14), only a little more than half the cohort (64.3%) had NMOSD. In cases with high positives (80–160 U/mL, n=14), 100% of patients met clinical criteria for NMOSD. Conclusions. Our data illustrates diagnostic uncertainty associated with the AQP4 ELISA, an assay that is still commonly ordered by clinicians despite the availability of more sensitive and specific tests to detect AQP4 autoantibodies in patients suspected of having NMOSD. In particular, low positive titer AQP4 ELISA results are particularly nonspecific for the diagnosis of NMOSD. The importance of accessibility to both sensitive and specific AQP4 testing cannot be overemphasized in clinical practice.http://dx.doi.org/10.1155/2021/8692328 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jon P. Williams Justin R. Abbatemarco Jonathan J. Galli Stefanie J. Rodenbeck Lisa K. Peterson Thomas R. Haven Meagan Street John W. Rose John E. Greenlee M. Mateo Paz Soldan Stacey L. Clardy |
spellingShingle |
Jon P. Williams Justin R. Abbatemarco Jonathan J. Galli Stefanie J. Rodenbeck Lisa K. Peterson Thomas R. Haven Meagan Street John W. Rose John E. Greenlee M. Mateo Paz Soldan Stacey L. Clardy Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay Multiple Sclerosis International |
author_facet |
Jon P. Williams Justin R. Abbatemarco Jonathan J. Galli Stefanie J. Rodenbeck Lisa K. Peterson Thomas R. Haven Meagan Street John W. Rose John E. Greenlee M. Mateo Paz Soldan Stacey L. Clardy |
author_sort |
Jon P. Williams |
title |
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay |
title_short |
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay |
title_full |
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay |
title_fullStr |
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay |
title_full_unstemmed |
Aquaporin-4 Autoantibody Detection by ELISA: A Retrospective Characterization of a Commonly Used Assay |
title_sort |
aquaporin-4 autoantibody detection by elisa: a retrospective characterization of a commonly used assay |
publisher |
Hindawi Limited |
series |
Multiple Sclerosis International |
issn |
2090-2662 |
publishDate |
2021-01-01 |
description |
Objective. Aquaporin-4 (AQP4) serum autoantibodies are detected by a variety of methods. The highest sensitivity is achieved with cell-based assays, but the enzyme-linked immunosorbent assay (ELISA) is still commonly utilized by clinicians worldwide. Methods. We performed a retrospective review to identify all patients at the University of Utah who had AQP4 ELISA testing at ARUP Laboratories from 2010 to 2017. We then reviewed their diagnostic evaluation and final diagnosis based on the ELISA titer result. Results. A total of 750 tests for the AQP4 ELISA were analyzed, and 47 unique patients with positive titers were identified. Less than half of these patients (49%) met the clinical criteria for neuromyelitis optica spectrum disorder (NMOSD). In cases of low positive titers (3.0–7.9 U/mL, n=19), the most common final diagnosis was multiple sclerosis (52.6%). In the moderate positive cohort (8.0–79.9 U/mL, n=14), only a little more than half the cohort (64.3%) had NMOSD. In cases with high positives (80–160 U/mL, n=14), 100% of patients met clinical criteria for NMOSD. Conclusions. Our data illustrates diagnostic uncertainty associated with the AQP4 ELISA, an assay that is still commonly ordered by clinicians despite the availability of more sensitive and specific tests to detect AQP4 autoantibodies in patients suspected of having NMOSD. In particular, low positive titer AQP4 ELISA results are particularly nonspecific for the diagnosis of NMOSD. The importance of accessibility to both sensitive and specific AQP4 testing cannot be overemphasized in clinical practice. |
url |
http://dx.doi.org/10.1155/2021/8692328 |
work_keys_str_mv |
AT jonpwilliams aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT justinrabbatemarco aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT jonathanjgalli aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT stefaniejrodenbeck aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT lisakpeterson aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT thomasrhaven aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT meaganstreet aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT johnwrose aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT johnegreenlee aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT mmateopazsoldan aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay AT staceylclardy aquaporin4autoantibodydetectionbyelisaaretrospectivecharacterizationofacommonlyusedassay |
_version_ |
1716829229382893568 |